Table 2 Characteristics of CEC measurements per treatment arm
Month of CEC count | n | Median (CECs per 4 ml) | Range (CECs per 4 ml) | n | Median (CECs per 4 ml) | Range (CECs per 4 ml) | n | Median (CECs per 4 ml) | Range (CECs per 4 ml) |
|---|---|---|---|---|---|---|---|---|---|
Bevacizumab+Lomustine | Bevacizumab single agent | Lomustine single agent | |||||||
Baseline | 47 | 54 | 9–282 | 40 | 78 | 7–793 | 37 | 52 | 7–292 |
4 weeks | 43 | 128 | 19–2122 | 41 | 76 | 17–1056 | 35 | 65 | 7–2232 |
6 weeks | 39 | 170 | 24–1796 | 38 | 103 | 4–1330 | 32 | 71 | 16–442 |
